PLASMIC Score for Thrombotic Thrombocytopenic Purpura
How likely is severe ADAMTS13 deficiency (TTP) in a patient with thrombotic microangiopathy?
Calculator
Fields marked * are required. Units can be changed per field.
Result
Your result will appear here
Complete the inputs and select Calculate. Results update instantly for point scores.
About this tool
Seven-item score predicting severe ADAMTS13 deficiency before results are available.
Intended use
Adults with suspected thrombotic microangiopathy.
Outcome
Severe ADAMTS13 deficiency (activity < 10%)
Time horizon
Current episode
Derivation population
US multi-institutional TMA registry.
Limitations
- Validated in adults only.
- Does not replace ADAMTS13 testing.
Clinical problems
Evidence
Evidence level
Moderate evidence
Externally validated, or an established physiological equation whose clinical thresholds rest on consensus; guideline support limited or mixed. Methodology
References
- Original publicationBendapudi PK, Hurwitz S, Fry A, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol 2017;4:e157-e164. Find on PubMed (opens in a new tab)
Version history
| Version | Formula | Effective | Reviewer | Changes |
|---|---|---|---|---|
| v1.0.0 | Bendapudi 2017 | 2026-10-03 | — | Initial implementation with reference test vectors. |
Related tools
Clinical decision support only. Interpret results in the context of the individual patient and current guidance; HumanPulse does not replace professional medical judgment.